Combined with other BER deficiencies observed in MS (e.g., MBD4/NTHL1 downregulation), this variant likely contributes to mitochondrial DNA instability and amplified neuroinflammation [14]. The gene discussed is MBD4; the disease is myeloid sarcoma.